MPTF
MPTF
What we do
New Techniques
The future of cancer care
Although medicine has made lots of progress in treating many cancers, much progress still needs to be made. Amongst the hardest cancers to treat, and those with the poorest outcomes, are gastrointestinal and rare cancers. Fortunately, new techniques mean that treatment for these cancers can be personalised, dramatically improving survival rates.
Funding Assistance
The challenge of access
Imagine being diagnosed with one of these harder-to-treat cancers, being told that new treatments were now available that are much more successful, but then realising that you cannot afford the innovative new treatment. This is the problem that My Personal Therapeutics Foundation exists to address. If you think you could benefit from funding assistance then please contact us through our confidential form.
How we help patients
My Personal Therapeutics Foundation provides financial aid to patients with gastrointestinal and rare cancers, so that they can access the very latest in personalised treatments. We support anyone, in any country, provided you can be helped by our therapeutic partner, and meet our financial aid criteria. If you think that you meet our criteria then please contact us through our confidential form:
Donate Now
Donate to make and make a REAL difference.
Find a Lifeline for Nora
$10.00 - $5,000.00At just 7, Nora's vibrant spirit shines despite her battle with the devastating ECHS1 Deficiency, Leigh-like Syndrome. Her adorable joy is inspiring yet makes her parent's search for therapies more urgent. Already Noa has her vision impaired, is tube-fed, and is unable to walk or talk. Yet, their warrior princess finds so much joy in music, cartoons, and her loving family, including Lulu, her loyal pup. The heartache of losing Anna, her sister, further drives the search for a custom therapy that will give Nora, and others like her, the chance to more fully embrace life.View more details...SelectQuantity
Cover A Patient's Personalised Drug Combination
$13,768.00Cover the costs of the full genetic and AI drug combination discovery process including backup combination discovery.QuantityBe Part of a Patient Journey
$100.00 - $2,000.00Be part of funding a patient through the initial sequencing.SelectQuantityAbout MPTF
The MPT Foundation was founded in 2019, to assist patients needing financial assistance in accessing cutting-edge personalised cancer therapeutics specifically from VivanTx.
BILL LIAO
MD
Chinese-Australian entrepreneur, venture investor, diplomat, author, and speaker with a distinguished record in the areas of business, development and community activism. Bill is an earth citizen dedicated to a world that works for all life while civilization thrives. Multi unicorn entrepreneur, GP at SOSv, Chair of Ki Tua Fund and Chair of WeForest.org
LAURA TOWART
CEO
Laura formed the My Personal Therapeutics Foundation to raise funds to support the identification of new therapeutic options for patients who need them. The MPTF supports patients who could benefit from personalised treatment but who otherwise wouldn't be able to afford such therapies. Laura is the founder and CEO of Vivan Therapeutics, a company with a ground breaking personalised approach to cancer and rare disease.
OLIVER SMITH
STRATEGY ADVISOR
Oliver is a strategy adviser and applied ethicist. He was Strategy Director and Head of Ethics at Koa Health from 2016 to 2022. He was also a Senior Civil Servant in the UK Department of Health and a Policy Adviser in the Prime Minister’s Strategy Unit under Tony Blair.
NATHAN MCNALLY
STRATEGY ADVISOR
Nathan has worked and led multimillion-pound initiatives supporting tech entrepreneurs for the last 10 years. Founder and CEO of the P4 Precision Medicine Accelerator to create a more coherent, connected pathway for AI enabled precision medicine companies to scale. In 2024 co-founded Raer, a Scottish based biotech focused on rare disease.
STEVE LEWIS
LEAD DESIGNER
With 15 years of practice in helping people understand the wavy—and often blurry—line between user behavior and user experience, Steve has led the way in creating beautiful, aesthetic UIs driven by human-centric discovery and insight across several industries.
GERAINT JOHN
STRATEGY ADVISOR
Geraint John is a dad of 3 and lost his wife Deb to Pancreatic at the aged of 43 in September 2022. Since Debs' passing, he has become a spokesperson for grief via The BBC, Multiple Podcasts and his own social media channels. As a result he has a developed a dedicated following from people who are either grieving or supporting a partner or loved one in their Cancer journey.
